ProfileGDS4718 / 209377_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 95% 99% 95% 95% 98% 98% 96% 95% 96% 97% 96% 98% 95% 98% 98% 96% 95% 98% 99% 95% 96% 96% 97% 96% 98% 96% 98% 96% 98% 98% 98% 93% 94% 96% 97% 97% 97% 97% 98% 97% 97% 97% 99% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.824396
GSM549102patient 115, normal, homogenized [OPG study]10.348695
GSM549104patient 119, normal, homogenized [OPG study]11.962599
GSM549108patient 138, normal, homogenized [OPG study]10.281895
GSM549119patient 077, normal, homogenized [OPG study]10.432295
GSM549133patient 032, cancer, homogenized [OPG study]11.666898
GSM549139patient 042, cancer, homogenized [OPG study]11.377698
GSM549099patient 107, normal, homogenized [OPG study]10.553596
GSM549109patient 139, normal, homogenized [OPG study]10.368695
GSM549110patient 046, normal, homogenized [OPG study]10.660996
GSM549114patient 063, normal, homogenized [OPG study]11.049197
GSM549122patient 082, normal, homogenized [OPG study]10.451896
GSM549134patient 033, cancer, homogenized [OPG study]11.36498
GSM549136patient 036, cancer, homogenized [OPG study]10.353195
GSM549140patient 044, cancer, homogenized [OPG study]11.143998
GSM549111patient 047, normal, homogenized [OPG study]11.328198
GSM549113patient 057, normal, homogenized [OPG study]10.813996
GSM549132patient 031, cancer, homogenized [OPG study]10.250595
GSM549137patient 038, cancer, homogenized [OPG study]11.49998
GSM549142patient 047, cancer, homogenized [OPG study]11.39599
GSM549100patient 110, normal, homogenized [OPG study]10.350795
GSM549107patient 135, normal, homogenized [OPG study]10.74496
GSM549115patient 068, normal, homogenized [OPG study]10.743196
GSM549116patient 072, normal, homogenized [OPG study]10.834497
GSM549120patient 078, normal, homogenized [OPG study]10.500396
GSM549131patient 030, cancer, homogenized [OPG study]11.215998
GSM549118patient 074, normal, homogenized [OPG study]10.532996
GSM549129patient 027, cancer, homogenized [OPG study]11.267298
GSM549123patient 088, normal, homogenized [OPG study]10.653896
GSM549124patient 006, cancer, homogenized [OPG study]11.12898
GSM549126patient 015, cancer, homogenized [OPG study]11.316598
GSM549128patient 025, cancer, homogenized [OPG study]11.296898
GSM549103patient 117, normal, homogenized [OPG study]9.6888693
GSM549117patient 073, normal, homogenized [OPG study]10.11194
GSM549138patient 041, cancer, homogenized [OPG study]10.408796
GSM549141patient 045, cancer, homogenized [OPG study]10.945797
GSM549130patient 028, cancer, homogenized [OPG study]10.696497
GSM549101patient 111, normal, homogenized [OPG study]10.89697
GSM549105patient 128, normal, homogenized [OPG study]10.91297
GSM549106patient 134, normal, homogenized [OPG study]11.898898
GSM549112patient 048, normal, homogenized [OPG study]10.89497
GSM549125patient 011, cancer, homogenized [OPG study]10.806897
GSM549127patient 024, cancer, homogenized [OPG study]10.849697
GSM549135patient 035, cancer, homogenized [OPG study]11.850899